Development of a molecular multimarker assay for the analysis of circulating tumor cells in adenocarcinoma patients.
Abstract
BACKGROUND
The analysis of circulating tumor cells (CTCs) is emerging as a promising diagnostic tool in oncology. However, even if a
variety of methods for CTC isolation have been already developed, their specificity and/or sensitivity still remain problematic.
The aim of this study was to develop an immunomagnetic/real-time reverse transcription polymerase chain reaction (RT-PCR)
assay for the molecular detection of circulating tumor cells (CTCs) in peripheral blood (PB) of adenocarcinoma cancer patients.
METHODS
The presence of CTCs was evaluated in 945 PB blood samples from 247 adenocarcinoma cancer patients and in 42 healthy controls
by immunomagnetic enrichment using the antibodies BM7 and VU1D9 followed by real-time RT-PCR analysis of the marker genes
KRT19, MUC1, EPCAM, CEACAM5, BIRCS, SCGB2A2, and ERBB2.
RESULTS
The developed assay showed not only high specificity, as none of the healthy controls were found positive for the multimarker
gene panel, but also great sensitivity as CTCs were detected in adenocarcinomas arising from 10 different organs. According
to tumor primary origin, CTC positivity was detected in 33.3% of Ampulla of Vater adenocarcinomas, 69.6% of bile ducts adenocarcinomas,
61.3% of breast adenocarcinomas, 61.3% of cardia adenocarcinomas, 60.6% of colon adenocarcinomas, 66.7% of esophagus adenocarcinomas,
57.1% of pancreas adenocarcinomas, 66.7% of rectum adenocarcinomas, 33.3% of small intestine adenocarcinomas, and 62.2% of
stomach adenocarcinomas.
CONCLUSIONS
Our results suggest that the current developed technique can be used to detect CTCs in all major adenocarcinomas, with great
sensitivity without compromising specificity.
Authors
de Albuquerque A, Kubisch I, Ernst D, Breier G, Stamminger G, Fersis N, Stölzel U, Boese-Landgraf J, Eichler A, Kaul S
Institution
Department of Pathology, Technische Universität Dresden, Dresden, Germany. a.albuquerque@skc.de
Source
Clinical laboratory 58:5-6 2012 pg 373-84MeSH
AdenocarcinomaAdult
Aged
Aged, 80 and over
Female
Gene Expression Profiling
Gene Expression Regulation, Neoplastic
Humans
Immunomagnetic Separation
Male
Middle Aged
Molecular Diagnostic Techniques
Neoplasm Proteins
Neoplastic Cells, Circulating
Reverse Transcriptase Polymerase Chain Reaction
Sensitivity and Specificity
Tumor Markers, Biological
Pub Type(s)
Journal ArticleResearch Support, Non-U.S. Gov't
Language
eng
PubMed ID
22783565
Log In

